Retraction Note to: British Journal of Cancer (2004) 91, 2042–2047; https://doi.org/10.1038/sj.bjc.6602254, published online 14 December 2004
The Editor-in-Chief has retracted this article because serious concerns have been raised about integrity of the data. Specifically:
Figure 1a—the Id-1 and Actin bands for the Skov3 panel appear to be very similar.
The Actin bands in the Ovca433 panel in Figure 1a seem very similar to the Actin bands for the Ovca433 panel in Figure 4a.
Figure 1a—it appears that some images have been published earlier with different labels by some of the same authors.1,2
In Figure 1b the Actin band for the Ovca420 panel and the Actin band for the Ovca432 panel seem to be mirror images.
The authors were unable to provide raw data. The data reported in this article are therefore unreliable.
S.W. Tsao agrees to this retraction. The editor was not able to obtain a current email address for X. Zhang, M.-T. Ling, H. Feng, Y.C. Wong and X. Wang.
References
Ling, M., Wang, X. S., Ouyang, X., Xu, K., Tsao, S. W. & Wong, Y. C. Id-1 expression promotes cell survival through activation of NF-kB signalling pathway in prostate cancer cells. Oncogene 22, 4498–4508, https://doi.org/10.1038/sj.onc.1206693 (2003).
Cheung, H. W., Ling, M.-t, Tsao, S. W., Wong, Y. C. & Wang, X. Id-1-induced Raf/MEK pathway activation is essential for its protective role against taxol-induced apoptosis in nasopharyngeal carcinoma cells. Carcinogenesis 25, 881–887, https://doi.org/10.1093/carcin/bgh087 (2004).
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Zhang, X., Ling, MT., Feng, H. et al. Retraction Note to: Id-1 stimulates cell proliferation through activation of EGFR in ovarian cancer cells. Br J Cancer 124, 1748 (2021). https://doi.org/10.1038/s41416-021-01322-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41416-021-01322-z
